Página principal > Resultados de la búsqueda: Ritchlin, Christopher
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
13 p, 2.0 MB Differences in oxylipin profile in psoriasis versus psoriatic arthritis / Coras, Roxana (Universitat Autònoma de Barcelona) ; Kavanaugh, Arthur (University of California San Diego. Department of Medicine) ; Kluzniak, Angela (University of Rochester. Department of Medicine) ; Holt, Dustina (University of Rochester. Department of Medicine) ; Weilgosz, Amy (University of Rochester. Department of Medicine) ; Aaron, Armando (University of California San Diego. Department of Pharmacology) ; Quehenberger, Oswald (University of California San Diego. Department of Pharmacology) ; Ritchlin, Christopher (University of Rochester. Department of Medicine) ; Guma, Monica 1971- (Universitat Autònoma de Barcelona)
Oxylipins are biological lipids that have been implicated in inflammation. We previously found that certain oxylipins correlated with clinical manifestations in psoriatic arthritis (PsA) patients. Here, we compare oxylipin profiles in PsA patients and those with psoriasis (PsO) without inflammatory arthritis to identify oxylipins that associate with specific disease manifestations to better understand disease pathogenesis and identify new biomarkers. [...]
2021 - 10.1186/s13075-021-02575-y
Arthritis research & therapy, Vol. 23 (july 2021)  
Registro completo - Creative Commons
2.
11 p, 255.5 KB Maintenance of clinical efficacy and radiographic benefit through two years of ustekinumab therapy in patients with active psoriatic arthritis : results from a randomized, placebo-controlled phase III trial / Kavanaugh, Arthur (University of California) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Gottlieb, Alice B. (Tufts Medical Center) ; Ritchlin, Christopher (University of Rochester) ; Li, Shu (Janssen Pharmaceutica) ; Wang, Yuhua (Janssen Pharmaceutica) ; Mendelsohn, Alan M. (Janssen Pharmaceutica) ; Song, Michael (Janssen Pharmaceutica) ; Zhu, Yaowei (Janssen Pharmaceutica) ; Rahman, Proton (Memorial University of Newfoundland) ; McInnes, Iain B. (University of Glasgow) ; Universitat Autònoma de Barcelona
To evaluate the efficacy and safety of ustekinumab through 2 years in adult patients with active psoriatic arthritis (PsA). A total of 615 adult patients with active PsA were randomized to placebo, ustekinumab 45 mg, or ustekinumab 90 mg, at weeks 0, 4, and every 12 weeks through week 88 (last dose). [...]
2015 - 10.1002/acr.22645
Arthritis Care & Research, Vol. 67, issue 12 (Dec. 2015) , p. 1739-1749  
Registro completo - Creative Commons

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos